The MPL gene gives cells the instructions for a receptor that helps the bone marrow make platelets, the blood cells that help stop bleeding, and supports early blood-forming cells. If it does not work properly, a person may have very low platelet counts with easy bruising or bleeding, or changes in how blood cells grow. In medicine, this gene is important because some variants are linked to inherited low-platelet conditions, while others are found in certain bone marrow blood cancers.
What is a gene?
A gene is a stretch of DNA that holds information cells can use to make molecules or manage processes in the body. Some genes provide the instructions for producing proteins, which serve as the working parts of cells. Other genes mainly regulate when certain processes happen, where they occur, and how strongly they are carried out. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. To explore this topic in greater depth, you can learn more in the LearnHub.
Overview
MPLGene function
What if the gene works
The MPL gene helps bone marrow cells respond to thrombopoietin, a natural signal that supports platelet production. It also helps maintain stem cells in bone marrow, which support steady blood cell renewal.
Risk
What if the gene does not work
Variants in the MPL gene can weaken or overactivate signals that control platelet production. Milder changes may cause lifelong low platelets, while more severe variants can lead to bone marrow failure; other variants are linked to myeloproliferative blood conditions.
Treatment
What does that mean for your treatment
For people with pathogenic variants in the MPL gene, thrombopoietin receptor agonists such as romiplostim or eltrombopag are generally not expected to help because the receptor itself is impaired. Management often centers on supportive care, and allogeneic stem cell transplant is the established definitive treatment when marrow failure develops.
Conditions associated with MPL
Gene function
What if the gene works
Healthy blood cell production depends on steady signals inside the bone marrow. The MPL gene makes a receptor, a protein on the cell surface that receives thrombopoietin, a natural messenger in the blood. This signaling helps control platelet production and supports early blood-forming cells.
The MPL gene helps bone marrow cells respond to thrombopoietin, the main signal for making platelets. This guides large marrow cells called megakaryocytes as they grow and mature, so your body can keep a healthy platelet supply.
Its protein also works on early blood-forming stem cells in the bone marrow. These signals help those cells stay alive, renew themselves, and remain ready to produce new blood cells over time.
MPL acts like an antenna on the cell surface, passing outside messages to the cell's inner control system. This helps blood-forming cells adjust growth, timing, and survival in a coordinated way.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the MPL gene can weaken the receptor by changing its shape, lowering its stability, or stopping it from reaching the cell surface, which reduces signaling in platelet-forming cells. Other variants keep the receptor switched on too much, even without the usual signal. This helps explain how MPL gene variants affect platelet production: milder loss-of-function variants may leave some signaling, while more severe variants often lead to earlier or more marked blood platelet problems.
How variants are linked to conditions
Variants in the MPL gene are linked to several blood conditions. Inherited pathogenic variants can cause congenital amegakaryocytic thrombocytopenia, a condition with very low platelet counts and later bone marrow failure, and some inherited variants lead to familial thrombocytosis, with persistently high platelets. Acquired MPL variants are also found in some people with essential thrombocythemia or primary myelofibrosis.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are widespread in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant connected with a condition indicates a possible association rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some instances, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For MPL, risk usually depends most on whether a harmful gene change is present, either inherited or acquired in blood cells over time. In people with MPL-related blood conditions, older age and common clotting risks such as smoking or high blood pressure can raise the chance of complications.
Inheritance of MPL variants
How MPL gene variants are inherited depends on the specific condition and the particular variant. In families with MPL-related hereditary thrombocythemia, the pattern is usually autosomal dominant, so a parent carrying the variant can pass it to a child with a 50% chance in each pregnancy. Other MPL-related conditions, including congenital amegakaryocytic thrombocytopenia, follow an autosomal recessive pattern, which means a child usually inherits one altered copy from each parent. Because of this, the inheritance pattern for the MPL gene is not the same in every family.
What does my MPL result mean for my family?
What an MPL result means for relatives depends on the specific condition linked to that result. Some inherited MPL changes run in families in a dominant way, so close relatives may also carry the same change and may wish to discuss testing. Other MPL changes are linked to a recessive condition, which means parents can be healthy carriers and brothers or sisters could also be affected or be carriers.
Genetic information
Genetic testing
How you find out about variants
To find out if you carry a variant in the MPL gene, doctors can use genetic testing for MPL gene variants on a blood or saliva sample. The lab reads the DNA sequence of the MPL gene and looks for changes, either on its own or as part of a broader blood condition panel.
When should I consider getting a genetic test?
Genetic testing for the MPL gene may be considered if someone has very low platelet counts starting in infancy, repeated bleeding or bruising, or a family history of inherited platelet conditions. It may also be included when doctors are evaluating unexplained very high platelet counts or certain bone marrow blood cancers.
A genetic result is only one part of your health story
Genetic findings can provide useful insight, but what they can tell you varies with the condition and the kind of variant present. Over time, the way the body functions is also shaped by factors like lifestyle, environment, age, and medical history. In some conditions, particularly those affected by many genes, genetic information offers context rather than certainty and is best understood alongside other aspects of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results may help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is absorbed, broken down, moved through the body, or how strongly it acts at its target. This helps explain why the same treatment works well for one person, seems weaker for another, or causes more side effects in some people.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medicines. It studies links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medications, genes can influence how strongly a drug works or how the body handles it. This information can support more informed, individualized treatment choices. More detail on this topic is available in the LearnHub.
Drugs influenced by the MPL gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in routine medication decisions, so general concerns about treatment, side effects, or how well a medicine is working are best discussed with your doctor. In research, MPL changes in some blood conditions are being studied for possible links to treatment response, but this is not yet a standard guide for choosing medicines.
History
The MPL gene entered medical genetics through cancer research in the late 1980s, when scientists linked it to a virus associated with a myeloproliferative leukemia in mice. Building on this early work, scientists uncovered more about the gene when the human version was cloned in the early 1990s and connected to blood cell production. Researchers then identified inherited MPL variants in people with severe low platelet counts from infancy, helping define congenital amegakaryocytic thrombocytopenia. In the 2000s, acquired MPL variants such as MPL W515L and MPL W515K became important in the study of myeloproliferative neoplasms. These findings helped place the MPL gene at the center of modern blood cancer genetics and inherited platelet conditions.